Dynamics of morbidity and mortality from malignant neoplasms among the population of Amur Oblast (2014–2023)
https://doi.org/10.34215/1609-1175-2025-3-67-72
Abstract
Objective. To assess the area-specific indicators of morbidity and mortality from malignant neoplasms among the population of the Amur Oblast (Russia) in the period from 2014 to 2023. Materials and methods. Official data of the Oncology Service (forms 35 and 7) and the Federal State Statistics Service were processed using standard statistical software instruments. Results. In 2023, in the Amur Oblast of the Far Eastern Federal District, 3954 new cases of malignant neoplasms were registered, which exceed the number registered in 2014 by 31.3%. In males, the average incidence rate amounted to 312.17 ± 8.40о/оооо (compared to 293.09 ± 6.47о/оооо in 2020) per 100,000 population with an increment of 31.0%. In females, this indicator increased to 249.34о/оооо (compared to 232.35о/оооо in 2020) with an increment of 23.4%. In the structure of primary morbidity, skin, breast, tracheal, bronchial, lung, and prostate cancers dominated. The number of patients detected through active screening increased to 23.9%, compared to 20.4% in 2014. The ratio of registered patients to newly-detected cases (cohort accumulation index) increased to 6.1, compared to 5.9 in 2014. The number of patients with stages I-II of malignant neoplasms increased to 56.2%, compared to 52.0% in 2014. Along that, the number of patients with advanced forms of tumor process decreased to 22.4%, compared to 25.3% in 2014. The average value of the statistical indicator of mortality in males amounted to 182.02 ± 3.74 о/оооо (compared to 182.76 ± 3.50 о/оооо in 2020) per 100 000 population, being higher than in females (92.61 ± 1.03 о/оооо and 93.43 ± 0.90 о/оооо, respectively). Tumors of trachea, bronchus, and lung, breast, colon, and stomach were leading in the structure of total mortality. Conclusion. Insufficient number of oncology specialists, insufficiently active screening of patients to detect early stages of the disease, ineffective work of primary healthcare units to treat background and precancerous diseases – all these factors are obstacles to improving the quality of healthcare for cancer patients in accordance with the requirements of modern medicine.
About the Authors
V. P. Gordienko
Amur State Medical Academy
Russian Federation
Russian Federation
Victor P. Gordienko, Dr. Sci. (Med.), Professor, Head of the Department of Radiation Diagnostics, Radiation Therapy with an Oncology Course
95 Gorky str., Blagoveshchensk, 675000, Russia
A. D. Viter
Amur Regional Oncologic Dispensary
Russian Federation
Russian Federation
Blagoveshchensk
Y. V. Skabyolkina
Amur State Medical Academy
Russian Federation
Russian Federation
Blagoveshchensk
References
1. Malignant tumors in Russia in 2023 (morbidity and mortality). Ed. by Kaprin AD, Starinsky VV, Shakhzadova AO., Moscow; 2024. 276 p. (In Russ.).
2. Cancer care for the population of Russia in 2023. Ed. by Kaprin AD, Starinsky VV, Shakhzadova AO., Moscow; 2024. 262 p. (In Russ.).
3. Malignant tumors in Russia in 2014 (morbidity and mortality). Ed. by Kaprin AD, Starinsky VV, Petrova GV., Moscow; 2015. 250 p. (In Russ.).
4. Cancer care for the population of Russia in 2014. Ed. by Kaprin AD, Starinsky VV, Shakhzadova AO., Moscow; 2015. 235 p. (In Russ.).
5. Zhuikova LD, Choynzonov EL, Ananina OA, Pikalova LV, Kononova GA. The prevalence of oncological diseases among the population of the Siberia region and the Far East. Health Care of the Russian Federation. 2023;67(1):64–71. (In Russ.). doi: 10.47470/0044-197X-2023-67-1-64-71
6. Higginson J, Muir CS, Munoz N. Human Cancer: Epidemiology and Environmental Causes. Cambridge: Cambridge University Press; 1999; 577 p.
7. Liu J, Gan T, Hu W, Li Y. Current status and perspectives in environmental oncology. Chronic Dis Transl Med. 2024;10(4):293–301. doi: 10.1002/cdt3.148
8. Kehm RD, Lloyd SE, Burke KR, Terry MB. Advancing environmental epidemiologic methods to confront the cancer burden. Am J Epidemiol. 2025;194(1):195–207. doi:10.1093/aje/kwae175
9. Fan Y, Hu C, Xie X, Weng Y, Chen C, Wang Z, He X, Jiang D, Huang S, Hu Z, Liu F. Effects of diets on risks of cancer and the mediating role of metabolites. Nat Commun. 2024;15(1):5903.
10. Caprara G, Pallavi R, Sanyal S, Pelicci PG. Dietary Restrictions and Cancer Prevention: State of the Art. Nutrients. 2025;17(3):503. doi: 10.3390/nu17030503
11. Cancer Epidemiology in the USSR and the USA. Ed. by Blokhin NN, Shneiderman MA, Moscow: Meditsina, 1979. 384 p. (In Russ.).
12. Russian Statistical Yearbook. 2023. Rosstat. М., 2023. 701 p. (In Russ.).
13. Merabishvili VM. The Index accuracy – the most important criterion of an objective assessment of activity of oncological service for all localizations of malignant tumors, irrespective of level of lethality of patients. Problems in Oncology. 2019;65(4):510–515. (In Russ.).
14. Amur Statistical Yearbook 2023: statistical collection. Blagoveshchensk: Amurstat; 2023; 192 p. (In Russ.).
15. Petrova GV, Gretzova OP, Kaprin AD, Starinsky VV. Characteristics and calculation methods of medical and statistical indicators used in oncology. Practical recommendations. Moscow; 2014; 40 p. (In Russ.).
16. Avdeev YuA. The Far East: How to Stop Population Outflow and Make it Attractive? (polemical reflections). Living Standards of the Population in the Regions of Russia. 2021;17(3):299–313. (In Russ.). doi: 10.1918/1Isprr.2021.17.3.1
Review
For citations:
Gordienko V.P., Viter A.D., Skabyolkina Y.V. Dynamics of morbidity and mortality from malignant neoplasms among the population of Amur Oblast (2014–2023). Pacific Medical Journal. 2025;(3):67-72. (In Russ.) https://doi.org/10.34215/1609-1175-2025-3-67-72
Views:
10
Email this article 